CVE-2023-33364
HIGHCVSS 8.8/10EPSS 1.55%
Last modified
CVE-2023-33364 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.. EPSS estimates a 1.55% chance of exploitation in the next 30 days.
Description
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Supremainc | Biostar 2 | < 2.9.1 |
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33364Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release Notes, Vendor Advisory
- https://claroty.com/team82/disclosure-dashboard/cve-2023-33364Third Party Advisory
- https://kb.supremainc.com/knowledge/doku.php?id=en:release_note_291Release Notes, Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-33364?
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
How severe is CVE-2023-33364?
CVE-2023-33364 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 1.55% probability of exploitation in the next 30 days.
How do I fix CVE-2023-33364?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-33364?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST